PGNY Progyny, Inc.

Progyny, Inc. is a medical device company, which engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools. Its services include egg freezing, IVF treatment, surrogacy, podcast, adoption, and Eeva Test. The company was founded on April 03, 2008 and is headquartered in New York, NY.

$29.43  +0.38 (1.31%)
As of 07/01/2022 16:00:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Health Information Services
Index country:  USA
Country of incorporation:  USA
IPO date:  10/25/2019
Outstanding shares:  91,944,185
Average volume:  765,239
Market cap:   $2,670,978,574
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BKWD3M9

---

Valuation   (See tab for details)

---

PE ratio:   48.69
PB ratio:   10.64
PS ratio:   4.85
Return on equity:   19.87%
Net income %:   10.09%